Incretin-modulated beta cell energetics in intact islets of Langerhans
Hypoglycemia: While GLP-1 medications themselves rarely cause hypoglycemia (low blood sugar) when used as monotherapy, combining them with a mechanism of action that causes hypoglycemia such as insulin or sulfonylureas can increase the risk of hypoglycemia
We strive to optimize the benefits of GLP-1 medications, including their potential cardiovascular advantages, to enhance the overall well-being of our patients
This can include lifting weights, using resistance bands, or doing bodyweight exercises like squats and lunges. dont neglect aerobic exercise : Aim for at least 150 minutes of moderate-intensity aerobic activity each week, such as brisk walking, Ewing advised
Advertisement Supported by What We Know About Weight-Loss Drugs Is Rapidly Changing The widespread use of drugs like Ozempic is giving scientists a clearer picture than ever of their effects
Yeah, Im a journalist, and I did hope my experience could be instructive